Abbonarsi

Calcium Phosphate Cement loaded with 10% vancomycin delivering high early and late local antibiotic concentration in vitro - 23/11/18

Doi : 10.1016/j.otsr.2018.07.007 
Gaoyang Chen a, 1, Bo Liu c, 1, He Liu a, Hanyang Zhang a, Kerong Yang a, Qingyu Wang a, Jianxun Ding b, Fei Chang a,
a Department of orthopaedic surgery, 2nd Hospital of Jilin University, No. 218, Ziqiang street, Nanguan District, Changchun 130041, China 
b Key laboratory of polymer ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China 
c Department of orthopaedic surgery, the First Hospital of Jilin University, Changchun, China 

Corresponding author at: department of orthopaedic surgery, 2nd Hospital of Jilin University, No. 218, Ziqiang street, Nanguan District, Changchun 130041, China.department of orthopaedic surgery, 2nd Hospital of Jilin UniversityNo. 218, Ziqiang street, Nanguan DistrictChangchun 130041China

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

Antibiotics impregnated calcium phosphate cement (CPC) has emerged as a local treatment of osteomyelitis. However, there is no study investigating the optimal concentrations of vancomycin (VCM) included in CPC to obtain prolonged drug release (≥8 weeks) and also with enough compressive strength (>the normal cancellous bone, 11MPa) for osteomyelitis therapy. Therefore, we bring forward two questions: 1) Was antibiotic activity of the eluates correlated to the load of antibiotics within the cement? 2) Were the mechanical properties of CPC affected by VCM-loading?

Hypothesized

There was an optimal concentrations of vancomycin (VCM) loaded in CPC which could provide sufficient effective antibacterial time (≥8 weeks) and enough compressive strength (>11MPa).

Materials and methods

CPC specimens were obtained by incorporating different doses (weigh ratios of 0%, 5%, 10%, 15%, 20%, 25 and 30%) of injectable VCM into CPC. The antibacterial effect of released VCM solution against Staphylococcus aureus was assessed by inhibition ring assays. The physicochemical properties such as compressive strengths were characterized and compared among these specimens.

Results

Drug release profiles showed only 5 and 10% VCM-loaded CPC displayed a long enough drug release time (at least 8 weeks) and maintained the eluate concentrations (>4μg/mL) with effective antibacterial ability. The concentration of VCM in 10% group at 8th week was twice higher than 5% group. Compressive strength test showed that the proportional increase of VCM/CPC ratios resulted in a significant decrease of compressive strength (r=−0.906, p<0.001).

Conclusion

10% VCM-loaded CPC offered the optimal physicochemical properties and drug releasing profile and appears as the most suitable concentration for clinical use.

Level of evidence

III.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Calcium phosphate cement, Vancomycin, Osteomyelitis therapy, Mechanical strength


Mappa


© 2018  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 104 - N° 8

P. 1271-1275 - dicembre 2018 Ritorno al numero
Articolo precedente Articolo precedente
  • Impact of setting up a bone and joint infection referral center on arthroscopic treatment of septic arthritis of the knee and shoulder: Retrospective study
  • Marion Besnard, Damien Babusiaux, Pascal Garaud, Philippe Rosset, Louis Bernard, Louis-Romé Le Nail, Julien Berhouet, Orthopedics and Traumatology Society of Western France (SOO) c
| Articolo seguente Articolo seguente
  • The best knot and suture configurations for high-strength suture material. An in vitro biomechanical study
  • Dominik C. Meyer, Elias Bachmann, Alexandre Lädermann, Georg Lajtai, Thorsten Jentzsch

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.